Protocol Ledger

NCT03895437 · Phase II · TERMINATED

Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients

Interventional Phase II clinical trial protocol NCT03895437 sponsored by Tolerion in Endocrinology, Obesity, and Metabolic, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-06-17 Enrollment: 78 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03895437
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)78 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03895437
Protocol FieldVerified Registry Value
NCT IdentifierNCT03895437
Consolidated Lead SponsorTolerion
Therapeutic Condition CohortEndocrinology, Obesity, and Metabolic
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment78 participants (ACTUAL)
Registered Start Date2019-06-17
WhyStopped ClassificationUnspecified

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI